GEVO at a glance
Gevo, Inc. (GEVO, SEC CIK 1392380) filed its latest 10-K annual report on March 5, 2026, a 10-Q quarterly report on November 10, 2026, an 8-K current report on November 19, 2026 and Form 4 insider filings as recently as November 18, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), Gevo, Inc. (GEVO) reported revenue of $160.6 million (up 849.3% from FY2024) and a net loss of $33.8 million. Diluted EPS was -$0.14.
- As of September 30, 2026, 27 institutional investment managers tracked by SignalX reported holding Gevo, Inc. (GEVO) shares worth $78.8 million in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by Bowron Kimberly T on September 3, 2026 of 1,221 shares at $1.71 per share.
- In the last 90 days, GEVO insiders reported 0 open-market purchases ($0) and 3 open-market sales ($10K) on Form 4, a net sale of $10K.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $160.6M
- +849.3% vs prior year
- Insiders · 90 days
- 0 buys · 3 sells
- Net −$10K
- 13F holders
- 27 funds
- $78.8M · +2 vs prior quarter
- Latest 8-K
- Nov 19, 2026
- Item 7.01
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Risk Factors
- No material changes to 2025 Annual Report risk factors
- Unknown or currently immaterial risks could materially adversely affect results
- Carried-forward risks include potential effects on business, financial condition and cash flows
Management Discussion & Analysis
- Quarterly revenue $83.0M, up $40.2M YoY, driven by GevoND revenue of $77.5M vs $38.2M
- Net income $25.1M vs $7.6M loss YoY, operating margin 36.4% vs (8.6)%
- Best segment GevoND: $77.5M revenue, up $39.2M YoY, including $29.4M CFR credit revenue
- Worst segment RNG production: 91,729 MMBtu vs 92,396 YoY, LCFS generation down 7% to 33,889
- Cash $67.6M, operating cash flow $12.0M vs $(33.4)M YoY, capital investments $51.6M through nine months
AI summary of the GEVO 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 7.01: Regulation FD Disclosure
- Renewable natural gas business update, including revised carbon intensity score
- Updated financial outlook covering 2026 and 2027
Item EX-99.1: Item EX-99.1
- Third-party validation supports improved RNG carbon intensity recognition under the updated 45ZCF-GREET model
- RNG economics expected to increase approximately $15 million annually, up from more than $10 million previously estimated
Item 2.02: Results of Operations and Financial Condition
- Q3 2026 financial results announced for quarter ended September 30, 2026
- Exhibit 99.1 contains the press release with Gevo’s detailed results
Item EX-99.1: Item EX-99.1
- Record Q3 revenue $83 million, gross profit $48 million and net income $23 million, versus $43 million revenue and $8 million loss last year
- Adjusted EBITDA $44 million, up from $7 million, with operating cash flow $41 million and quarter-end cash $68 million
Item 5.02: Departure/Appointment of Directors or Principal Officers
- K’Lynne Johnson appointed Class II independent director, term running through 2027 annual meeting
- Annual compensation: $85,000 cash retainer plus $63,000 equity grant
Item EX-99.1: Item EX-99.1
- K’Lynne Johnson appointed to Gevo’s board, effective November 4, 2026
- Brings sustainable-technology, commercialization, manufacturing, and transformation expertise relevant to Gevo’s low-carbon fuels strategy
Item 7.01: Regulation FD Disclosure
- Press release announces Ms. Johnson’s appointment to Gevo’s Board
- Board addition may affect governance, oversight and strategic direction
AI summaries of GEVO 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for GEVO
Don't miss the next GEVO filing
- Alerts as it files. A push when GEVO files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut GEVO, by share count.
- Ask anything. An AI agent that reads every GEVO filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Johnson KLynne | A | Nov 4, 2026 | 49,219 | - |
| Bowron Kimberly T | Sell | Sep 3, 2026 | 1,221 | $1.71 |
| Bloom Paul D | Sell | Sep 3, 2026 | 1,514 | $1.71 |
| Gruber Patrick R. | Sell | Sep 3, 2026 | 3,333 | $1.70 |
| Barber James J | Buy | Aug 21, 2026 | 50,000 | $1.54 |
| Kettner David Michael | Buy | Aug 21, 2026 | 12,500 | $1.55 |
| Werpy Todd Allen | A | Aug 20, 2026 | 62,583 | - |
| Bloom Paul D | M | Aug 13, 2026 | 50,000 | $1.18 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $16.9M | $160.6M |
| Operating Income | - | -$90.8M | -$20.2M |
| Net Income | -$66.2M | -$78.6M | -$33.8M |
| Op. Margin | - | -536.9% | -12.6% |
| Net Margin | - | -464.9% | -21.1% |
| Balance Sheet | |||
| Total Assets | - | $583.9M | $718.9M |
| Equity | $557.4M | $489.5M | $466.3M |
| ROE | -11.9% | -16.1% | -7.3% |
| Per Share | |||
| EPS | $-0.28 | $-0.34 | $-0.14 |
| Cash Flow | |||
| Operating CF | - | -$57.4M | -$13.4M |
| CapEx | $54.5M | $51.1M | $30.1M |
Source: XBRL data in Gevo, Inc. (GEVO)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate GEVO share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 27 | $78.8M |
| Q2 2026 | 25 | $94.2M |
| Q1 2026 | 25 | $163.4M |
| Q4 2025 | 25 | $116.0M |
| Q3 2025 | 25 | $104.2M |
| Q2 2025 | 23 | $61.7M |
| Q1 2025 | 19 | $32.2M |
| Q4 2024 | 16 | $55.9M |
- Citadel Advisors LLC+1.80M (+148%)
- Millennium Management+533.4K (+119%)
- Citigroup+227.4K (+165%)
- JPMorgan Chase & Co+147.9K (+121%)
- Morgan Stanley+141.8K (+51%)
- State Street Corp−2.99M (-22%)
- Invesco Ltd−1.80M (-32%)
- Vanguard Portfolio Management LLC−533.8K (-10%)
- Vanguard Capital Management LLC−200.1K (-2%)
- Bank of America Corp−157.1K (-7%)
- Franklin Resources+25.8K
- Principal Financial Group+16.6K
- StoneX Group Inc.+10.2K
- FMR LLC (Fidelity)−64.0K
Source: 13F-HR filings on SEC EDGAR (aggregated from 185 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
GEVO filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 8-K | Nov 19, 2026 | - | Analysis | - |
| 4 | Nov 18, 2026 | - | - | - |
| 10-Q | Nov 10, 2026 | Sep 30, 2026 | Analysis | |
| 8-K | Nov 10, 2026 | - | Analysis | - |
| 8-K | Oct 28, 2026 | - | Analysis | - |
| 4 | Sep 4, 2026 | - | - | - |
| 4 | Sep 4, 2026 | - | - | - |
| 4 | Sep 4, 2026 | - | - | - |
| 8-K | Aug 26, 2026 | - | Analysis | - |
| 4 | Aug 24, 2026 | - | - | - |
| 4 | Aug 24, 2026 | - | - | - |
| 4 | Aug 24, 2026 | - | - | - |
| 4 | Aug 13, 2026 | - | - | - |
| 4 | Aug 7, 2026 | - | - | - |
| 4 | Aug 7, 2026 | - | - | - |
| SC 13G | Aug 7, 2026 | - | - | |
| 4 | Aug 7, 2026 | - | - | - |
| 4 | Aug 7, 2026 | - | - | - |
| 8-K | Aug 6, 2026 | - | Analysis | - |
| 10-Q | Aug 6, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Jul 16, 2026 | - | Analysis | - |
| 8-K | Jul 15, 2026 | - | Analysis | - |
| 4 | Jun 15, 2026 | - | - | - |
| 4 | Jun 15, 2026 | - | - | - |
| 4 | Jun 15, 2026 | - | - | - |
Related Health Care companies
- CDXS · CODEXIS, INC.Industrial Organic Chemicals
- FF · FutureFuel Corp.Industrial Organic Chemicals
- GPRE · Green Plains Inc.Industrial Organic Chemicals
- REX · REX AMERICAN RESOURCES CorpIndustrial Organic Chemicals
- SXT · SENSIENT TECHNOLOGIES CORPIndustrial Organic Chemicals
- VGAS · Verde Clean Fuels, Inc.Industrial Organic Chemicals
- SAFX · XCF Global, Inc.Industrial Organic Chemicals
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
GEVO SEC filings: frequently asked questions
Are GEVO insiders buying or selling?
In the last 90 days, Gevo, Inc. (GEVO) officers, directors and 10% owners reported no open-market purchases and 3 open-market sales worth $10,348 by 3 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold GEVO stock?
As of September 30, 2026, the largest Gevo, Inc. (GEVO) holders among the 13F filers tracked by SignalX were BlackRock ($24.2 million), State Street Corp ($13.7 million), Vanguard Capital Management LLC ($13.2 million), Vanguard Portfolio Management LLC ($6.5 million), Invesco Ltd ($5.0 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was GEVO's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), Gevo, Inc. (GEVO) reported revenue of $160.6 million (up 849.3% from FY2024) and a net loss of $33.8 million. Diluted EPS was -$0.14. The figures come from the XBRL data in the 10-K.
What did GEVO report in its latest 8-K?
Gevo, Inc. (GEVO) filed an 8-K on November 19, 2026 reporting Item 7.01 (Regulation FD Disclosure). Renewable natural gas business update, including revised carbon intensity score.
What are the latest GEVO SEC filings?
Gevo, Inc. (GEVO) filed its latest 10-K annual report on March 5, 2026, a 10-Q quarterly report on November 10, 2026, an 8-K current report on November 19, 2026 and a Form 4 insider filing on November 18, 2026.
What is GEVO's SEC CIK number?
Gevo, Inc. (GEVO)'s SEC Central Index Key (CIK) is 1392380. EDGAR lists every GEVO filing under that number.
Ask anything about GEVO
The research agent reads GEVO's filings, financials, insider trades and 13F holders, then answers with sources.